PMB-ALCEN

PMB, a subsidiary of the ALCEN group based in Peynier, France, specializes in the design and manufacture of complex particle accelerators and high-tech systems for the medical and research sectors. The company is a leader in nuclear medicine, notably through its iMiGiNE system, which is a unique, automated center for the production of injectable radiopharmaceuticals for PET imaging. PMB is also at the forefront of radiotherapy innovation with FLASHKNiFE, a system dedicated to FLASH radiotherapy that delivers high-dose radiation in extremely short pulses to spare healthy tissue. Their core expertise includes ultra-high vacuum technology, ceramic-to-metal brazing, and particle physics. By integrating cyclotrons and automated chemistry, PMB provides end-to-end solutions for decentralized radiopharmaceutical production. The company collaborates closely with prestigious institutions like the Institut Curie and CHUV to advance cancer treatment technologies.